Long-term clinical outcome of AIDS-related Kaposi's sarcoma during highly active antiretroviral therapy.
about
Treatment of severe or progressive Kaposi's sarcoma in HIV-infected adultsCost-effectiveness of serum cryptococcal antigen screening to prevent deaths among HIV-infected persons with a CD4+ cell count < or = 100 cells/microL who start HIV therapy in resource-limited settingsPitfalls of practicing cancer epidemiology in resource-limited settings: the case of survival and loss to follow-up after a diagnosis of Kaposi's sarcoma in five countries across sub-Saharan AfricaKSHV targets multiple leukocyte lineages during long-term productive infection in NOD/SCID mice.Imatinib: a breakthrough of targeted therapy in cancer.Risk factors influencing antibody responses to Kaposi's sarcoma-associated herpesvirus latent and lytic antigens in patients under antiretroviral therapyMechanisms of Kaposi's Sarcoma-Associated Herpesvirus Latency and ReactivationA randomized controlled trial of highly active antiretroviral therapy versus highly active antiretroviral therapy and chemotherapy in therapy-naive patients with HIV-associated Kaposi sarcoma in South AfricaThe clinical characteristics of 80 cases of acquired immunodeficiency syndrome-associated Kaposi's sarcoma in Xinjiang Autonomous Region and the effect of different treatments on the prognosisPhase 2 study of pegylated liposomal doxorubicin in combination with interleukin-12 for AIDS-related Kaposi sarcoma.Role of radiotherapy in local control of non-AIDS associated Kaposi's sarcoma patients in Korea: a single institution experiencePulmonary Kaposi Sarcoma: An Uncommon Cause of Respiratory Failure in the Era of Highly Active Antiretroviral Therapy-Case Report and Review of the Literature.Predictors of immune reconstitution inflammatory syndrome associated with Kaposi's sarcoma: a case report.Updating vital status by tracking in the community among patients with epidemic Kaposi sarcoma who are lost to follow-up in sub-Saharan Africa.Malignancies in women with HIV infection.Persistent Kaposi sarcoma in the era of highly active antiretroviral therapy: characterizing the predictors of clinical response.
P2860
Q24193874-13156C75-B1B4-4E2D-9032-978317A9AD30Q24600270-0451E03B-B1C1-4150-9A28-57DB2B62DA2CQ30386031-100A763A-D827-46F9-89E8-220BF00F3E77Q30440843-14EFFEA7-56B8-4CF9-A753-97896B6BE3E5Q33747261-0AF83755-4E14-4544-8AEC-10B3A0ED29D0Q34635757-47EE36D2-9827-477E-97E6-3323B4CC61A5Q35010647-718C03B8-3FA5-495C-992F-AAF54D293A93Q35989731-2A4A5A08-2886-47DC-9E08-FCA1987B2B10Q36411953-4DE2D5C5-0BC0-4E61-B9CB-FC31013D12F4Q36447950-E9CD5BE8-3AB7-4DF5-A169-A8304E73AD09Q36537044-4785226E-CE8E-4C2C-9130-09C7AE81132AQ37410777-8689B017-DB10-47C8-818F-E24DB826513AQ38258034-DDFE470B-F16D-43B1-906E-B0FD2117725EQ38848962-8EF9CD62-7B89-4122-8A87-7E045EA09BFBQ39010145-F03FC88A-C586-455A-8EA3-75C813890E67Q41956982-EBF1E49A-4FCA-4084-9076-F71037E069E1
P2860
Long-term clinical outcome of AIDS-related Kaposi's sarcoma during highly active antiretroviral therapy.
description
2005 nî lūn-bûn
@nan
2005 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Long-term clinical outcome of ...... active antiretroviral therapy.
@ast
Long-term clinical outcome of ...... active antiretroviral therapy.
@en
type
label
Long-term clinical outcome of ...... active antiretroviral therapy.
@ast
Long-term clinical outcome of ...... active antiretroviral therapy.
@en
prefLabel
Long-term clinical outcome of ...... active antiretroviral therapy.
@ast
Long-term clinical outcome of ...... active antiretroviral therapy.
@en
P2093
P1476
Long-term clinical outcome of ...... active antiretroviral therapy.
@en
P2093
Anita De Rossi
Anna Maria Cattelan
Luigi Chieco-Bianchi
Marco Trevenzoli
Maria Luisa Calabrò
Marisa Zanchetta
Massimo Barbierato
Paola Gasperini
Paolo Cadrobbi
Savina Maria Luciana Aversa
P304
P577
2005-09-01T00:00:00Z